Healthcare provider profile · identity verified

Elizabeth Baum, MD

Internal Medicine · CANTON, OH · NPI 1245211564

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	628	53
Levothyroxine Sodium	Levothyroxine Sodium	520	44
Eliquis	Apixaban	423	37
Atorvastatin Calcium	Atorvastatin Calcium	319	51
Trazodone Hcl	Trazodone Hcl	290	52
Potassium Chloride	Potassium Chloride	255	56
Pantoprazole Sodium	Pantoprazole Sodium	251	47
Gabapentin	Gabapentin	229	30
Losartan Potassium	Losartan Potassium	213	25
Fluticasone Propionate	Fluticasone Propionate	198	45
Amlodipine Besylate	Amlodipine Besylate	192	29
Citalopram Hbr	Citalopram Hydrobromide	170	26
Mirtazapine	Mirtazapine	154	31
Metoprolol Tartrate	Metoprolol Tartrate	143	26
Lisinopril	Lisinopril	139	20
Metoprolol Succinate	Metoprolol Succinate	139	30
Prednisone	Prednisone	125	30
Omeprazole	Omeprazole	115	20
Cefdinir	Cefdinir	97	35
Tamsulosin Hcl	Tamsulosin Hcl	89	15
Duloxetine Hcl	Duloxetine Hcl	86	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	79	25
Memantine Hcl	Memantine Hcl	78	14
Hydrochlorothiazide	Hydrochlorothiazide	74	suppressed
Levetiracetam	Levetiracetam	74	suppressed
Clopidogrel	Clopidogrel Bisulfate	70	12
Carvedilol	Carvedilol	69	12
Donepezil Hcl	Donepezil Hcl	66	12
Diclofenac Sodium	Diclofenac Sodium	65	28
Metformin Hcl	Metformin Hcl	62	12
Alendronate Sodium	Alendronate Sodium	61	suppressed
Pravastatin Sodium	Pravastatin Sodium	61	suppressed
Latanoprost	Latanoprost	56	suppressed
Oxycodone Hcl	Oxycodone Hcl	54	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	53	suppressed
Ropinirole Hcl	Ropinirole Hcl	53	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	52	suppressed
Bumetanide	Bumetanide	50	12
Ondansetron Hcl	Ondansetron Hcl	42	suppressed
Simvastatin	Simvastatin	42	suppressed
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Sertraline Hcl	Sertraline Hcl	41	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	40	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	40	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Metformin Hcl Er	Metformin Hcl	36	suppressed
Promethazine Hcl	Promethazine Hcl	36	16
Lansoprazole	Lansoprazole	35	suppressed
Famotidine	Famotidine	34	suppressed
Colestipol Hcl	Colestipol Hcl	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Digoxin	Digoxin	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Nystop	Nystatin	29	16
Ezetimibe	Ezetimibe	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	11
Venlafaxine Hcl	Venlafaxine Hcl	26	suppressed
Baclofen	Baclofen	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	12
Montelukast Sodium	Montelukast Sodium	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	suppressed
Lactulose	Lactulose	22	suppressed
Ranolazine Er	Ranolazine	22	suppressed
Sotalol	Sotalol Hcl	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Atenolol	Atenolol	21	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	21	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Diclofenac Potassium	Diclofenac Potassium	20	suppressed
Methenamine Hippurate	Methenamine Hippurate	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Glipizide	Glipizide	19	suppressed
Sumatriptan	Sumatriptan	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Levofloxacin	Levofloxacin	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Desmopressin Acetate	Desmopressin Acetate	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Glatopa	Glatiramer Acetate	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Nystatin	Nystatin	17	13
Azithromycin	Azithromycin	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	suppressed
Cephalexin	Cephalexin	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Klayesta	Nystatin	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Risperidone	Risperidone	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Indapamide	Indapamide	13	suppressed
Lidocaine Hcl	Lidocaine Hcl	13	suppressed
Linzess	Linaclotide	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Moxifloxacin Hcl	Moxifloxacin Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Finasteride	Finasteride	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error